Literature DB >> 8546672

The mitogen-activated protein kinase pathway in rat islets of Langerhans: studies on the regulation of insulin secretion.

S J Persaud1, C P Wheeler-Jones, P M Jones.   

Abstract

The expression of mitogen-activated protein kinases (MAPKs) and MAPK kinases (MEKs) in rat islets of Langerhans and the involvement of MAPKs in regulated insulin secretion were examined. Two major isoforms of both MEK (45 and 46 kDa) and MAPK (42 and 44 kDa) were detected in rat islets and shown to be localized to insulin-secreting beta cells by detection of their expression in the beta cell line MIN6. The tyrosine phosphatase inhibitor sodium pervanadate, and, to a lesser extent, the serine/threonine phosphatase inhibitor okadaic acid, stimulated MAPK phosphorylation, as assessed by a shift in its electrophoretic mobility and by increased phosphotyrosine immunoreactivity of immunoprecipitated MAPK. The increase in MAPK phosphorylation stimulated by sodium pervanadate was not coupled to an increase in MAPK activity, but okadaic acid, either alone or in the presence of sodium pervanadate, caused an increase in myelin basic protein phosphorylation by MAPK. Neither okadaic acid nor sodium pervanadate, either individually or combined, stimulated insulin secretion. 4 beta-phorbol myristate acetate stimulated an increase in phosphorylation of the 42 kDa isoform of MAPK (erk2) in human umbilical vein endothelial cells, but neither it nor glucose affected either the phosphorylation state of islet erk2 or the activities of immunoprecipitated islet MAPKs. These results provide evidence for the presence of a regulated MAPK pathway in adult rat islets, but our data suggest that MAPK activation alone is not a sufficient stimulus for insulin secretion.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8546672      PMCID: PMC1216871          DOI: 10.1042/bj3130119

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

1.  MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo.

Authors:  H Sun; C H Charles; L F Lau; N K Tonks
Journal:  Cell       Date:  1993-11-05       Impact factor: 41.582

2.  Activation of MAP kinase associated with the priming effect of LHRH.

Authors:  R Mitchell; P J Sim; T Leslie; M S Johnson; F J Thomson
Journal:  J Endocrinol       Date:  1994-02       Impact factor: 4.286

3.  p42 mitogen-activated protein kinase and p90 ribosomal S6 kinase are selectively phosphorylated and activated during thrombin-induced platelet activation and aggregation.

Authors:  J Papkoff; R H Chen; J Blenis; J Forsman
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

4.  Tyrosine phosphorylation and activation of mitogen-activated protein kinases by thrombin in human platelets: possible involvement in late arachidonic acid release.

Authors:  S Nakashima; Y Chatani; M Nakamura; N Miyoshi; M Kohno; Y Nozawa
Journal:  Biochem Biophys Res Commun       Date:  1994-01-28       Impact factor: 3.575

5.  Differentiation of PC12 cells in response to a cAMP analogue is accompanied by sustained activation of mitogen-activated protein kinase. Comparison with the effects of insulin, growth factors and phorbol esters.

Authors:  S W Young; M Dickens; J M Tavaré
Journal:  FEBS Lett       Date:  1994-01-31       Impact factor: 4.124

Review 6.  MAP kinase kinase kinase, MAP kinase kinase and MAP kinase.

Authors:  C J Marshall
Journal:  Curr Opin Genet Dev       Date:  1994-02       Impact factor: 5.578

7.  Tyrosine phosphorylation of a mitogen-activated protein kinase-like protein occurs at a late step in exocytosis. Studies with tyrosine phosphatase inhibitors and various secretagogues in rat RBL-2H3 cells.

Authors:  F Santini; M A Beaven
Journal:  J Biol Chem       Date:  1993-10-25       Impact factor: 5.157

8.  AVP-induced activation of MAP kinase in vascular smooth muscle cells is mediated through protein kinase C.

Authors:  A Kribben; E D Wieder; X Li; V van Putten; Y Granot; R W Schrier; R A Nemenoff
Journal:  Am J Physiol       Date:  1993-10

9.  Thyrotropin-releasing hormone stimulates MAP kinase activity in GH3 cells by divergent pathways. Evidence of a role for early tyrosine phosphorylation.

Authors:  M Ohmichi; T Sawada; Y Kanda; K Koike; K Hirota; A Miyake; A R Saltiel
Journal:  J Biol Chem       Date:  1994-02-04       Impact factor: 5.157

10.  Control of MAP kinase activation by the mitogen-induced threonine/tyrosine phosphatase PAC1.

Authors:  Y Ward; S Gupta; P Jensen; M Wartmann; R J Davis; K Kelly
Journal:  Nature       Date:  1994-02-17       Impact factor: 49.962

View more
  6 in total

1.  Expression of cAMP-regulated guanine nucleotide exchange factors in pancreatic beta-cells.

Authors:  C A Leech; G G Holz; O Chepurny; J F Habener
Journal:  Biochem Biophys Res Commun       Date:  2000-11-11       Impact factor: 3.575

2.  Activation of mitogen-activating protein kinase by glucose is not required for insulin secretion.

Authors:  S Khoo; M H Cobb
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

3.  Estrogens directly potentiate neuronal L-type Ca2+ channels.

Authors:  Saumyendra N Sarkar; Ren-Qi Huang; Shaun M Logan; Kun Don Yi; Glenn H Dillon; James W Simpkins
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-24       Impact factor: 11.205

4.  AMP-activated protein kinase is activated by low glucose in cell lines derived from pancreatic beta cells, and may regulate insulin release.

Authors:  I P Salt; G Johnson; S J Ashcroft; D G Hardie
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

5.  The permissive effects of glucose on receptor-operated potentiation of insulin secretion from mouse islets: a role for ERK1/2 activation and cytoskeletal remodelling.

Authors:  J E Bowe; A Chander; B Liu; S J Persaud; P M Jones
Journal:  Diabetologia       Date:  2013-01-24       Impact factor: 10.122

6.  Transgenic overexpression of active calcineurin in beta-cells results in decreased beta-cell mass and hyperglycemia.

Authors:  Ernesto Bernal-Mizrachi; Corentin Cras-Méneur; Bo Ra Ye; James D Johnson; M Alan Permutt
Journal:  PLoS One       Date:  2010-08-03       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.